Vista Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹2.50Cr
Net Profits
₹0.97Cr
Net Profit Margins
-38.80%
Highlights
Revenue:

Vista Pharmaceuticals Ltd’s revenue fell -29.58% since last year same period to ₹2.50Cr in the Q2 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 33.69% jump in its revenue since last 3-months.

Net Profits:

Vista Pharmaceuticals Ltd’s net profit jumped 51.98% since last year same period to ₹0.97Cr in the Q2 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -12.79% fall in its net profits since last 3-months.

Net Profit Margins:

Vista Pharmaceuticals Ltd’s net profit margin jumped 31.81% since last year same period to -38.80% in the Q2 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 15.63% jump in its net profit margins since last 3-months.

FAQs

The revenue for Vista Pharmaceuticals Ltd in the Q2 results 2024 was ₹2.50Cr.

The net profit for Vista Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.97Cr.

The net profit margin for Vista Pharmaceuticals Ltd in the Q2 results 2024 was -38.80%.

The revenue for Vista Pharmaceuticals Ltd in the Q2 results 2023 was ₹3.55Cr.

The net profit for Vista Pharmaceuticals Ltd in the Q2 results 2023 was ₹-2.02Cr.

The net profit margin for Vista Pharmaceuticals Ltd in the Q2 results 2023 was -56.90%.